BriaCell Therapeutics Corp.
BCTX · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $3 | $124 | $1,045 | $993 |
| - Cash | $14 | $1 | $28 | $53 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$11 | $123 | $1,017 | $941 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$37 | -$7 | -$27 | -$34 |
| % Margin | – | – | – | – |
| Net Income | -$36 | -$7 | -$27 | -$34 |
| % Margin | – | – | – | – |
| EPS Diluted | -86.25 | -59.69 | -261.86 | -330.38 |
| % Growth | -44.5% | 77.2% | 20.7% | – |
| Operating Cash Flow | -$39 | -$33 | -$32 | -$16 |
| Capital Expenditures | $0 | -$1 | $0 | $0 |
| Free Cash Flow | -$39 | -$34 | -$32 | -$16 |